Journal Articles

2018 | 2017 | 2016 | 2015 | 2014 | 2013| 2012 | 2011 | 2010 | 2009

Aguila, E., M. Lopez-Ortega., L. M. G. Robledo. (2018). Non-contributory pension programs and frailty of older adults: Evidence from MexicoPloS one, 13(11), e0206792.

Vega, A., T. Porteny., & E. Aguila. (2018). The Role of Clinics in Determining Older Recent Immigrants’ Use of Health ServicesJournal of immigrant and minority health, 20(6), 1468-1475.

Gross, M. E., T. B. Dorff., D. I. Quinn., P. M. Diaz., O. O. Castellanos., & D. B. Agus. (2018). Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC). Clinical Genitourinary Cancer, 16(1), e11-e21.

Ailshire, J. (2018). Site of Death and Healthcare Utilization Prior to Death Among Older Adults in Europe and the USInnovation in Aging, 2(Suppl 1), 186.

Ailshire, J. (2018). The Role of Air Pollution in Healthy Aging. Innovation in Aging, 2(Suppl 1), 863.

Brown, L., & J. Ailshire. (2018). Is Exposure Enough ? Race/Ethnic Differences in Chronic Stress Exposure, Appraisal, and & Mental Health in Older Adults. Innovation in Aging, 2(suppl_1), 66-66.

Brown, L. L., Mitchell, U. A., & Ailshire, J. (2018). Disentangling the Stress Process: Race/Ethnic Differences in the Exposure and Appraisal of Chronic Stressors among Older AdultsThe Journals of Gerontology: Series B.

Brown, L. L., Y. S. Zhang., C. Mitchell., J. A. Ailshire. (2018). Does Telomere Length Indicate Biological, Physical, and Cognitive Health Among Older Adults? Evidence from the Health and Retirement Study. Journals of Gerontology: Biological Sciences, 73(12), 1626-1632.

Cicero, C., A. L. Nguyen., J. Swift., D. Ruddell., T. Banerjee., & J. Ailshire. (2018). Developing Lifespan Improvement Districts (LIDS): Lessons Learned from USC’s Age-Friendly Los Angeles Practicum. Innovation in Aging, 2(Suppl 1), 872.

Clark, C., & J. Ailshire. (2018). Profiles of Older Homeless Adults with Chronic Mental Health Problems in Los Angeles CountyInnovation in Aging, 2(Suppl 1), 976.

Frochen, S., & J. Ailshire. (2018). Residential Care in California: Evaluating the Distribution of Facilities and Access to care Among Older AdultsInnovation in Aging, 2(Suppl 1), 872.

Ailshire, J., S. Frochen., & S. Rodnyansky. (2018). Moving Preference and Determinants Among US Older Adults . Innovation in Aging, 2(Suppl 1), 873.

Gallo, H., Shim, H., Wilber, K., & Ailshire, J. (2018). Implications of Social Media Versus In-Person Communication for Feelings of Loneliness Among Older Adults Innovation in Aging, 2(Suppl 1), 332.

Ailshire, J., & C. García. (2018). Unequal Places: The Impacts of Socioeconomic and Race/Ethnic Differences in NeighborhoodsGenerations, 42(2), 20-27.

Garcia, C., M. A. Garcia., & J. A. Ailshire. (2018). Sociocultural variability in the Latino population: Age patterns and differences in morbidity among older US adultsDemographic Research, 38, 1605-1618.

Kim, J. K., Ailshire, J. A., & Crimmins, E. M. (2018). Twenty-year trends in cardiovascular risk among men and women in the United StatesAging clinical and experimental research, 1-9.

Lee, Y., I. Chi., & J. A. Ailshire. (2018). Life transitions and leisure activity engagement among older Americans: findings from a national longitudinal studyAgeing & Society, 1-28.

Ailshire, J., K. D. Lincoln., & L. L. Brown. (2018). AGING ON THE STREETS: THE EMERGING CRISIS OF OLDER HOMELESS ADULTS IN LOS ANGELES COUNTY. Innovation in Aging, 2(Suppl 1), 376.

Mitchell, U. A., Ailshire, J. A., & Crimmins, E. M. (2018). Change in Cardiometabolic Risk Among Blacks, Whites, and Hispanics: Findings From the Health and Retirement Study. The Journals of Gerontology: Series A, 74(2), 240-246.


Saenz, J. L., Wong, R., & Ailshire, J. A. (2018). Indoor air pollution and cognitive function among older Mexican adults. J Epidemiol Community Health, 72(1), 21-26.

Shim, H., Ailshire, J., Zelinski, E., & Crimmins, E. (2018). The Health and Retirement Study: Analysis of Associations Between Use of the Internet for Health Information and Use of Health Services at Multiple Time Points. Journal of medical Internet research, 20(5).

Axeen, S. (2018). Trends in opioid use and prescribing in Medicare, 2006-2012. Health Services Research 53 (5): 3309-28.

Menchine, M. D., Van Winkle, P., Ghobadi, A., Chen, Q., Axeen, S. A., & Sharp, A. L. (2018). 249 Opioid Prescribing from Emergency Departments and Risk of Long-Term Use in a Large, Managed Care NetworkAnnals of Emergency Medicine, 72(4), S99.

Santillanes, G., Lam, C. N., Axeen, S., & Menchine, M. D. (2018). 45 Trends in Emergency Department Mental Health Visits from 2009-2015Annals of Emergency Medicine, 72(4), S21.

Axeen, S., S. A. Seabury and M. Menchine. (2018). Emergency department contribution to the prescription opioid epidemic. Annals of Emergency Medicine 70 (5) 623-31.

Chen, A., D.M. Blumenthal., and A.B. Jena. (2018). Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances. JAMA Network Open. 1(8), e185805.

Chen, A. J. and D. P. Goldman. (2018). Productivity benefits of medical care: Evidence from US-based randomized clinical trials. Value in Health 21 (8): 905-10.

Chen, A. J., A. J. Graves, M. J. Resnick and M. R. Richards. (2018). Does spending more get more? Health care delivery and fiscal implications from a Medicare fee bump. Journal of Policy Analysis and Management 37 (4): 706-31.

Chen, A. J., X. Hu, A. B. Jena and D. P. Goldman. (2018). Trends in the economic value of newly approved cancer therapies in the US. Value in Health 21 (suppl. 1): S3.

Chen, A., A. T. Lo Sasso and M. R. Richards. (2018). Supply‐side effects from public insurance expansions: Evidence from physician labor markets. Health Economics, 27 (4): 690-708.


Cox, R. (2018). Mass Incarceration, Racial Disparities in Health, and Successful Aging. Generations, 42(2), 48-55.

Crimmins, E. M. (2018). Older Persons in The Netherlands and the United States: Similar in Trends in Life in Good Cognitive Health and Different in Trends in Life Without Disability/Poor Health. American Journal of Public Health, 108(12), 1582-1583.

Crimmins, E. (2018). PHYSIOLOGICAL STATUS AND SYSTEMIC FUNCTIONING IN THE HRS. Innovation in Aging, 2(Suppl 1), 210.

Crimmins, E. (2018). Trends in Mortality, Disease, and Physicological Status in the Older Population. Future Directions for the Demography of Aging: Proceedings of a Workshop. Published by National Academies Press.

Barcelo, H., Faul, J., Crimmins, E., & Thyagarajan, B. (2018). A Practical Cryopreservation and Staining Protocol for Immunophenotyping in Population StudiesCurrent Protocols in Cytometry, 84(1), e35.

Kang, H., Crimmins, E., & Ailshire, J. (2018). ASSOCIATION OF MULTIMORBIDITY WITH INCIDENT SHINGLES AMONG OLDER AMERICANSInnovation in Aging, 2(Suppl 1), 905.

Levine, M. E., & Crimmins, E. M. (2018). Is 60 the New 50? Examining Changes in Biological Age Over the Past Two Decades. Demography, 55(2), 387-402.

Levine, M., Crimmins, E., Horvath, S., & Ferrucci, L. (2018). METHYLATION LANDSCAPES UNDERLYING HUMAN BIOLOGICAL AGING. Innovation in Aging, 2(Suppl 1), 836.

Liu, Z., Chen, X., Gill, T. M., Ma, C., Crimmins, E. M., & Levine, M. E. (2018). Disentangling the contribution of childhood and adulthood circumstances and genetics to phenotypic aging: prospective cohort studybioRxiv, 384040.

Liu, Z., Kuo, P. L., Horvath, S., Crimmins, E., Ferrucci, L., & Levine, M. (2018). Phenotypic Age: a novel signature of mortality and morbidity riskbioRxiv, 363291.

Crimmins, E. M., Y. Saito, J. K. Kim et al. (2018). Educational differences in the prevalence of dementia and life expectancy with dementia: Changes from 2000 to 2010. Journals of Gerontology: Series B 73 (1) S20-28.

Sheehan, C., Domingue, B. W., & Crimmins, E. (2018). Cohort trends in the gender distribution of household tasks in the United States and the implications for understanding disability. Journal of aging and health, 0898264318793469.

Shim, H., Crimmins, E., & Ailshire, J. (2018). INTERNET USE AND SOCIAL CAPITAL: FINDINGS FROM THE NATIONAL HEALTH AND AGING TRENDS STUDY. Innovation in Aging, 2(Suppl 1), 560.

Crimmins, E. M., Shim, H., Zhang, Y. S., & Kim, J. K. (2018). Differences Between Men and Women in Mortality and the Health Dimensions of the Morbidity ProcessClinical chemistry, clinchem-2018.

Thomas, D., Seeman, T., Potter, A., Hu, P., Crimmins, E., Herningtyas, E. H., … & Frankenberg, E. (2018). HPLC-based Measurement of Glycated Hemoglobin using Dried Blood Spots Collected under Adverse Field ConditionsBiodemography and social biology, 64(1), 43-62.

Thyagarajan, B., Barcelo, H., Crimmins, E., Weir, D., Minnerath, S., Vivek, S., & Faul, J. (2018). Effect of delayed cell processing and cryopreservation on immunophenotyping in multicenter population studiesJournal of immunological methods, 463, 61-70.

Yen, K., Wan, J., Mehta, H. H., Miller, B., Christensen, A., Levine, M. E., … Crimmins, E., & Navarrete, G. (2018). Humanin Prevents Age-Related Cognitive Decline in Mice and is Associated with Improved Cognitive Age in HumansScientific reports, 8(1), 14212.

Deaton, A. (2018). What do self-reports of wellbeing say about life-cycle theory and policy?Journal of Public Economics.

Deaton, A., & Cartwright, N. (2018). Reflections on Randomized Control Trials. Social science & medicine (1982), 210, 86-90.

Deaton, A., & Cartwright, N. (2018). Understanding and misunderstanding randomized controlled trialsSocial Science & Medicine, 210, 2-21.

Case, A., & Deaton, A. (2018). Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?. Monographs, no 001975.

Le, Q. A., J. N. Doctor, L. A. Zoellner and N. C. Feeny. (2018). Effects of treatment, choice and preference on health-related quality-of-life outcomes in patients with post-traumatic stress disorder (PTSD). Quality of Life Research 27 (6), 1555-62.

MacEwan, J. P., Gill, T. M., Johnson, K., Doctor, J., Sullivan, J., Shim, J., & Goldman, D. P. (2018). Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions. The Journal of Nutrition, Health & Aging, 22(4), 1-6.

Doctor, J. N., A. Nguyen, R. Lev, J. Lucas, T. Knight, H. Zhao and M. Menchine. (2018). Opioid prescribing decreases after learning of a patient’s fatal overdose. Science 361 (6402): 588-90.

Doctor, J. N., J. Vaidya, X. Jiang … and D. Meeker. (2018). Efficient determination of equivalence for encrypted data. arXiv preprint arXiv:1803.03760.

Zetts, R. M., Stoesz, A., Garcia, A. M., Doctor, J., Gerber, J. S., Linder, J. A., & Hyun, D. Y. (2018, November). 1887. Primary Care Physicians’ Attitudes and Perceptions Toward Antibiotic Resistance and Outpatient Antibiotic Stewardship: A Qualitative Study. In Open Forum Infectious Diseases (Vol. 5, No. suppl_1, pp. S540-S540). US: Oxford University Press.

Vidmar, A. P., Pretlow, R., Borzutzky, C., Wee, C. P., Fox, D. S., Fink, C., Mittelman, S. D. (2018). An Addiction Model-Based Mobile Health Weight Loss Intervention in Adolescents with Obesity. Pediatric Obesity, 14(2), e12464.

Han, X., Fox, D. S., Chu, M., Dougherty, J. S., & McCombs, J. (2018). Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis. Journal of Managed Care & Specialty Pharmacy, 24(11), 1078-1085.

Gaudette, É., Pauley, G. C., & Zissimopoulos, J. M. (2017). Lifetime Consequences of Early-Life and Midlife Access to Health Insurance: A ReviewMedical Care Research and Review, 75(6), 655-720.

Ginsburg, P., Brandt, C., Patel, K, et al (2018). Medicare Graduate Medical Education Funding is Not Addressing the Primary Care Shortage: We Need a Radically Different Approach. USC-Brookings Schaeffer Initiative for Health Policy.

Pham, H., & Ginsburg, P. B. (2018). Payment and Delivery-System Reform—The Next PhaseNew England Journal of Medicine, 379(17), 1594-1596.

Berndt, E. R., Goldman, D. P., Rowe, J. (2019). Introduction to “Economic Dimensions of Personalized and Precision Medicine”. In Economic Dimensions of Personalized and Precision Medicine. Chicago, IL: University of Chicago Press.

Carrera, M., D. P. Goldman, G. Joyce and N. Sood. (2018). Do physicians respond to the costs and cost-sensitivity of their patients? American Economic Journal: Economic Policy 10 (1): 113-52.

Chen, C., D. P. Goldman, J. Zissimopoulos and J. W. Rowe. (2018). Multidimensional comparison of countries’ adaptation to societal aging. Proceedings of the National Academy of Sciences 115 (37): 9169-74.

Goldman, D. P., C. Chen, J. Zissimopoulos, J. W. Rowe … and J. Jackson. (2018). Opinion: Measuring how countries adapt to societal aging. Proceedings of the National Academy of Sciences 115 (3): 435-37.

Chou, J. W., A. R. Silverstein and D. P. Goldman. (2018). Impact of Medicaid treatment access policies on the hepatitis C epidemic. Value in Health 21: S87.

Cefalu, W. T., D. E. Dawes, G. Gavla, D. Goldman, W. H. Herman, K. Van Nuys … and A. L. Yatvin. (2018). Insulin access and affordability working group: Conclusions and recommendations. Diabetes Care 41 (6): 1299-1311.

Cefalu, W. T., Dawes, D. E., Gavlak, G., Goldman, D., Herman, W. H., Van Nuys, K., … & Yatvin, A. L. (2018). Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018; 41; 1299–1311. Diabetes Care, 41(8), 1831-1831.

Goldman, D. P., H. Fillit and P. Neumann. (2018). Accelerating Alzheimer’s disease drug innovations from the research pipeline to patients. Alzheimer’s & Dementia 14 (6): 833-36.

Franco, A., Goldman, D., Leive, A., & McFadden, D. (2018). A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis. In Measuring and Modeling Health Care Costs. University of Chicago Press.

Goldman, D. P. and K. Hagopian. (2018). It is time for universal coverage without breaking the bank. Journal of Policy Analysis and Management 37 (1): 182-88.

Goldman, D. P. and K. Hagopian. (2018). Medicare‐for‐all: Not our only option for universal coverage. Journal of Policy Analysis and Management 37 (1): 195-98.

Jena, A. B., A. Olenski, D. M. Blumenthal, R. W. Yeh, D. P. Goldman and J. Romley. (2018). Acute myocardial infarction mortality during dates of national interventional cardiology meetings. Journal of the American Heart Association 7 (6): e008230.

Kabiri, M., M. Brauer, J. Shafrin, J. Sullivan, T. M. Gill and D. P. Goldman. (2018). The long-term health and economic value of improved mobility among older adults in the United States. Value in Health 21 (7): 792-98.

Goldman, D. and D. Lakdawalla. (2018). The global burden of medical innovation. USC Leonard D Schaeffer Center for Health Policy & Economics Working Paper.

Shekelle, P. G., & Goldman, D. P. (2018). Development of a Group Judgment Process for Forecasts of Health Care Innovations. JAMA Network Open, 1(7), e185108-e185108.

Snider, J. T., M. Brauer, K. Batt, P. Karaca-Mandic, J. Zhang and D. P. Goldman. (2018). The social value of tisagenlecleucel, a CAR-T cell therapy, for the treatment of relapsed or refractory pediatric acute lymphoblastic leukemia in the United States: What are consequences of treatment delays? Journal of Clinical Oncology 36 (15 suppl.): 10529.

Turakhia, M. P., J. Shafrin, K. Bognar, J. Trocio, Y. Abdulsattar, D. Wiederkehr and D. P. Goldman. (2018). Estimated prevalence of undiagnosed atrial fibrillation in the United States. PloS One 13 (4): e0195088.

Goldman, D.P., K. Van Nuys., W. Cheng., J. Hlavka., L. Pani., S. Chassang., and E. Snowberg. (2018). A New Model for Pricing Drugs of Uncertain Efficacy. NEJM Catalyst.

Ward, A. S., M. Kabiri, A. Yucel … and D. P. Goldman. (2018). The long-term social value of better targeting G-Csf therapy to cancer patients at risk of febrile neutropenia. Value in Health 21 (S42-43).

Xie, Z., D. Goldman, A. L. Peters and J. A. Romley. (2018). Estimating the effects of extended-release formulations on adherence, HBA1C control and hospital outcomes. Value in Health, 21(S79).

Aliyev, E. R., Hay, J. W., Hwang, C. (2018). Cost-effectiveness comparison of ustekinumab, Infliximab, or adalimumab for the treatment of moderate-severe crohn’s disease in biologic-naïve patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(2), 118-128.

Aliyev, E. R., Hay, J. W., Hwang, C. (2018). The Cost-Effectiveness of Ustekinumab Compared to Infliximab And Adalimumab in Adult Patients with Moderate-Severe Crohn’s Disease (Tnf Naïve Population). Value in Health, 21(1), S84.

Bae-Shaaw, Y. H., Hay, J. W. (2018). The Cost Effectiveness Analysis of PD-1 And PD-L1 Agents Compared with Docetaxel for Second-Line Treatment of Advanced Non-Small Cell Lung Cancer. Value in Health, 21 (1), S30.

Cho, S. K., Hay, J. W., Barzi, A. (2018). Cost-effectiveness analysis of regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States. Clinical Colorectal Cancer, 17 (4), e751-e761.

Cho, S. K., Hay, J. W., Barzi, A. (2018). Cost-effectiveness analysis of regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer. Value in Health, 21(1), S1.

Cohen, B. G., Hay, J., Barzi, A. (2018). Cost-Effectiveness of Short-Course Radiotherapy Compared to Long-Course Chemoradiotherapy in the Treatment of Stage Iii Rectal Cancer Patients from the US Societal Perspective. Value in Health, 21(1), S32.

Cohen, B. G., Hay, J., Barzi, A. (2018). Threshold Analysis of a cost-effectiveness study for short-course radiation therapy compared to long-course chemoradiotherapy in the treatment of stage III Rectal Cancer. Radiation Oncology, 102(3), e401.

Gong, C. L., K. M. Zangwill, J. W. Hay, D. Meeker and J. N. Doctor. (2018). Behavioral economics interventions to improve outpatient antibiotic prescribing for acute respiratory infections: A cost-effectiveness analysis. Journal of General Internal Medicine: 1-9.

Gong, C. L., Dasgupta-Tsinikas, S., Zangwill, K. M., Bolaris, M., Hay, J. W. (2018). Management of Asymptomatic Term & Late Preterm Newborns Exposed to Maternal Intrapartum Fever: A Societal Cost Benefit Analysis of the Proposed “Triple I” Algorithm. Value in Health, 21 (1), S143-S144

Innis, B. D., Hay, J. W. (2018). Cost Effectiveness Analysis Of Evolocumab, A PCSK9 Inhibitor, From The US Societal Perspective. Value in Health, 21 (1), S60-S61.

Kawatkar, A. A., Hay, J. W., Stohl, W., & Nichol, M. B. (2018). Consistent estimation of polychotomous treatment effects with selection-bias and unobserved heterogeneity using panel data correlated random coefficients model. Health Services and Outcomes Research Methodology, 18(2), 75-95.

Kim, J., Hay, J. W. (2018). Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma. Value in Health, 21(1), S29.

Lam, J., Hay, J. W., Salcedo, J., Kenyon, N. J. (2018). A Cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. Journal of Asthma, 1-10.

Lam, J., Hay, J. W., Salcedo, J., Kenyon, N. J. (2018). A Cost-effectiveness analysis of reslizumab in poorly controlled eosinophilic asthma. Value in Health, 21 (1), S235.

Le, Q., Hay, J., Becker, R. V., Wang, Y. (2018). Economic analysis of abaloparatide in high-rsik postemenopausal women with osteoporosis in the United States – A Discrete-Event Simulation Model. Value in Health, 21(1), S197.

Hay, J. W., Lee, P., Jin, H., Guterman, J. J., Gross-Schulman, S., Ell, K., Wu, S. (2018). Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Mondel in Safety-Net Primary Care Patients with Type 2 Diabetes. Value in Health, 21 (5), 561-568.

Salcedo, J., Hay, J. W., Lam, J. (2018). Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrilation in patients with worsening renal function. International Journal of Cardiology, 282, 53-58.

Xu, Y., Hay, J. W., Barzi, A. (2018). Impact of Drug Substitution on Cost of Care: An Example of Economic Analysis of Cetuximab Versus Panitumumab. Cost Effectiveness and Resource Allocation, 16(1), 30.

Heckman, J. J. (2018). The Race Between Demand and Supply: Tingergen’s Pioneering Studies of Earnings Inequality. National Bureau of Economic Research Working Paper Series No. w25415.

Garcia, J. L., Heckman, J. J., Ziff, A. L. (2018). Early Childhood Education and Crime. Infant Mental Health Journal, 40 (1), 141-151.

Garcia, J. L., Heckman, J. J., Ziff, A. L. (2018). Gender differences in the benefits of an influential early childhood program. European Economic Review, 109, 9-22.

Heckman, J. J., Humphries, J. E., Veramendi, G. (2018). The Nonmarket Benefits of Education and Ability. Journal of Human Capital, 12(2), 282-304.

Heckman, J. J., Humphries, J. E., Veramendi, G. (2018). Returns to Education: The Casual Effects of Education on Earnings, Health, and Smoking. Journal of Political Economy, 126 (S1).

Heckman, J. J., Moktan, S. (2018). Publishing and Promotion in Economics: The Tyranny of the Top Five. Institute for New Economic Thinking Working Papers No. 82.

Heckman, J. J., Lazear, E. P., Murphy, K. M. (2018). Gary Becker Remembered. Journal of Political Economy, 126 (S1).

Barthold, D., Joyce, G., Wharton, W., Kehoe, P., & Zissimopoulos, J. (2018). The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicityPloS one, 13(11), e0206705.

Joyce, G., Henkhaus, L, Gascue, L., Zissimopoulos, J. (2018). Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare BeneficiariesHealth Affairs, 37:10, 1578-1586

Lakdawalla, D. N. (2018). Economics of the pharmaceutical industry. Journal of Economic Literature, 56(2), 397-449.

Baumgardner, J., Everson, K., Brauer, M., Zhang, J., Hao, Y., Liu, J., & Lakdawalla, D. N. (2018). CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments. Blood, 132(suppl 1), 322.

Baumgardner, J., A. Shahabi, M. Linthicum, S. Vine, C. Zacker and D. Lakdawalla. (2018). Greater spending associated with improved survival for some cancers in OCM-defined episodes. Journal of Managed Care and Specialty Pharmacy 24 (6): 504-13.

Baumgardner, J. R., Shahabi, A., Linthicum, M. T., Zacker, C., & Lakdawalla, D. N. (2018). Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care ModelJournal of oncology practice, 14(11), e699-e710.

Lakdawalla, D. N., J. A. Doshi, L. P. Garrison, C. E. Phelps, A. Basu and P. M. Danzon. (2018). Defining elements of value in health care—a health economics approach: An ISPOR Special Task Force report [3]. Value in Health 21 (2): 131-39.

Garrison, L. P., P. J. Neumann, R. J. Willke, A. Basu, P. M. Danzon, J. A. Doshi, M. F. Drummond, D. N. Lakdawalla … and M. C. Weinstein. (2018). A health economics approach to US value assessment frameworks: Summary and recommendations of the ISPOR Special Task Force report [7]. Value in Health 21 (2): 161-65.

Jena, A. B., Chou, J. W., Yoon, L., Aubry, W. M., Berger, J., Burton, W., … & Lakdawalla, D. N. (2018). Understanding and improving value frameworks with real-world patient outcomes. The American journal of managed care, 24(11), 506-509.

MacEwan, J. P., A. R. Silverstein, J. Shafrin, D. N. Lakdawalla, A. Hatch and F. M. Forma (2018). Medication adherence patterns among patients with multiple serious mental and physical illnesses. Advances in Therapy 35 (5): 671-85.

Phelps, C. E., D. N. Lakdawalla, A. Basu, M. F. Drummond, A. Towse, and P. M. Danzon. (2018). Approaches to aggregation and decision making—a health economics approach: an ISPOR Special Task Force report [5]. Value in Health 21(2): 146-54.

Lakdawalla, D., J. Reif and D. Bauer. (2018). Mortality risk, insurance, and the value of life. NBER Working Paper, 25055.

Sachs, R., Bagley, N., & Lakdawalla, D. N. (2018). Innovative contracting for pharmaceuticals and Medicaid’s best-price rule. Journal of Health Politics, Policy, and Law, 43(1), 5-18.

Shafrin, J., K. Bognar, K. Everson, M. Brauer, D. N. Lakdawalla and F. M. Forma. (2018). Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. ClinicoEconomics and Outcomes Research 10: 573-85.

Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walter, R. K., Levitt. P., et al. (2018). Analysis of Shared Heritability in Common Disorders of the Brain. Science, 360 (6395).

Levitt, P.; Eagleson, K. L. (2018). The Ingredients of Healthy Brain and Child Development. Washington University Journal of Law Policy,57, 75-88.

Heun-Johnson, H., Levitt, P. (2018). Differential Impact of Met Receptor Gene Interaction with Early-Life Stress on Neuronal Morphology and Behavior in Mice. Neurobiology of Stress, 8, 10-20.

Knoll, A. T., Jiang, K., Levitt, P. (2018). Quantitative Trait Locus Mapping and Analysis of Heritable Variation in Affiliative Social Behavior and Co-Occurring Traits. Genes, Brain, and Behavior, 17(5), e12431.

Li, M., Santpere, G., Kawasawa, Y. I., Evgrafov, O. V., Levitt, P., et. Al. (2018). Integrative Functional Genomic Analysis of Human Brain Development and Neuropsychiatric Risks. Science, 362 (6420).

Bertelli, A. M. and P. C. McCann. (2018). Decentralizing pork: Congressional roll-call voting, decentralized administration and distributive politics. Legislative Studies Quarterly, 43(1), 69-100.

Ni, W., D. Colayco, J. Hashimoto, K. Komoto, C. Gowda, B. Wearda and J. McCombs. (2018). Budget impact analysis of a pharmacist-provided transition of care program. Journal of Managed Care and Specialty Pharmacy 24 (2): 90-96.

Ni, W., Colayco, D., Hashimoto, J., Komoto, K., Gowda, C., Wearda, B., & McCombs, J. (2018). Reduction of healthcare costs through a transitions-of-care programAmerican Journal of Health-System Pharmacy, 75(10), 613-621.

Chen, F., X. Jiang, S. Wang, L. M. Schilling, D. Meeker, T. Ong … and J. Vaidya. (2018). Perfectly secure and efficient two-party electronic-health-record linkage. IEEE Internet Computing 22 (2): 32-41.

Kim, K. K., Khodyakov, D., Marie, K., Taras, H., Meeker, D., Campos, H. O., Ohno-Machado, L. (2018). A Novel Stakeholder Engagement Approach for Patient-Centered Outcomes Research. Medical Care, 56 (10 supp 1), S41.

McLaughlin, C., Zagory, J. A., Fenlon, M., Park, C., Lane, C. J., Meeker, D., Burd, R. S., Ford, H. R., Upperman, J. S., Jensen, A. R. (2018). Timing of Mortality in Pediatric Trauma Patients: A National Trauma Data Bank Analysis. Journal of Pediatric Surgery, 53 (2), 344-351.

Yadav, K., Meeker, D., Mistry, R., Doctor, J., Fleming-Dutra, K., Fleischman, R., … & May, L. (2018, November). 1633. A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection in Adults and Children in Emergency Department and Urgent Care Settings (MITIGATE Trial). In Open Forum Infectious Diseases (Vol. 5, No. Suppl 1, p. S43). Oxford University Press.

Melnick, G., K. Fonkych and J. Zwanziger. (2018). The California competitive model: How has it fared, and what’s next? Health Affairs, 37 (9), 1417-24.

O’Leary, J. F., Howe, J., Rich, J., & Melnick, G. (2018). Lessons from the Real World: Financial Incentives to Improve Glycemic Control in Patients with Type 2 DiabetesHealth, 10(02), 171.

Myerson, R. M. Health Insurance Literacy and Health Insurance Choices: Evidence from Affordable Care Act Navigator Programs. National Bureau of Economic Research.

Myerson, R. M., D. Lakdawalla, L. D. Colantonio, M. Safford and D. Meltzer. (2018). Effects of expanding health screening on treatment: What should we expect? What can we learn? National Bureau of Economic Research, w24347.

Myerson, R., T. Lu, I. Tonnu-Mihara and E. S. Huang. (2018). Medicaid eligibility expansions may address gaps in access to diabetes medications. Health Affairs 37 (8): 1200-7.

Kwatkar, A. A., J. W. Hay, W. Stohl and M. B. Nichol. (2018). Consistent estimation of polychotomous treatment effects with selection-bias and unobserved heterogeneity using panel data correlated random coefficients model. Health Services and Outcomes Research Methodology 18 (2): 75-95.

Skinner, M. W., Chai-Adisaksopha, C., Curtis, R., Frick, N., Nichol M., Noone, D., O’Mahony, B., Page, D., Stonebraker, J. S., Iorio, A. (2018). The Patient Reported Outcomes, Burdens, and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot and Feasibility Studies, 4 (58).

Romley, J. and P. Ginsburg (2018). Improving Bundled Payments in the Medicare Program. USC-Brookings Schaeffer Initiative for Health Policy.

Baldassano, R. N., A. Shahabi, S. A. Seabury, D. Lakdawalla … and G. R. Lichtenstein. (2018). P014 Average annual healthcare costs for pediatric and adult patients with Crohn’s disease or ulcerative colitis. Inflammatory Bowel Diseases 24 (suppl. 1): S6.

Seabury, S. A., Frasco, M. A., van Eijndhoven, E., Sison, S., & Zacker, C. (2018). The impact of self-and physician-administered cancer treatment on work productivity and healthcare utilization. Research in Social and Administrative Pharmacy, 14(5), 434-440.

Seabury, S. A., É. Gaudette, D. P. Goldman … and K. Boase. (2018). Assessment of follow-up care after emergency department presentation for mild traumatic brain injury and concussion: Results from the TRACK-TBI study. JAMA Network Open 1 (1): e180210

Heun-Johnson, H., Seabury, S. A., Menchine, M., Claudius, I., Axeen, S., Lakshmanan, A. (2018). Association between maternal serious mental illness and adverse birth outcomes. BMJ Publishing Group, 66(1), 193-194. – found to be published in Journal of Perinatology in 2019.

Ly, D. P., Seabury, S. A., & Jena, A. B. (2018). Characteristics of US Physician Marriages, 2000–2015: An Analysis of Data From a US Census SurveyAnnals of internal medicine, 1-3.

Nuckols, T. K., Conlon, C., Robbins, M., Dworsky, M., Lai, J., Roth, C. P., Levitan, B., Seabury, S … & Asch, S. M. (2018). Quality of care and patient‐reported outcomes in carpal tunnel syndrome: A prospective observational studyMuscle & Nerve, 57(6), 896-904.

Powell, D., & Seabury, S. (2018). Medical Care Spending and Labor Market Outcomes: Evidence from Workers’ Compensation ReformsAmerican Economic Review, 108(10), 2995-3027.

Shrestha, A., Shah, A., Everson, K., Huber, C., Seabury, S., O’Sullivan, A. K., & Weiden, P. J. (2018). Outcomes Among Patients Prescribed Atypical Long-Acting Injectables Vs Oral Antipsychotic Therapy Following an Acute Event for Schizophrenia. Value in Health, 21, S188.

Chatterjee, C., Joshi, R., Sood, N., & Boregowda, P. (2018). Government health insurance and spatial peer effects: New evidence from IndiaSocial Science & Medicine, 196, 131-141.

Huckfeldt, P. J., B. A. Weissblum, J. J. Escarce, P. Karaca-Mandic and N. Sood. (2018). Do skilled nursing facilities selected to participate in preferred provider networks have higher quality and lower costs? Health Services Research.

Sood, N., Shier, V., Nakata, H., Iorio, R., & Lieberman, J. R. (2018). The Impact of Comprehensive Care for Joint Replacement Bundled Payment Program on Care Delivery. The Journal of Arthroplasty, 34(4), 609-612.

Sood, N., D. Ung, A. Shankar and B. L. Strom. (2018). A novel strategy for increasing access to treatment for hepatitis c virus infection for Medicaid beneficiaries. Annals of Internal Medicine 169 (2): 118-19.

Sood, N. and Z. Wagner. (2018). Social health insurance for the poor: Lessons from a health insurance programme in Karnataka, India. BMJ Global Health 3 (1).

Weissblum, L., P. Huckfeldt, J. Escarce, P. Karaca-Mandic and N. Sood. (2018). Skilled nursing facility participation in Medicare’s bundled payments for care improvement initiative: A retrospective study. Archives of Physical Medicine and Rehabilitation (October).

Zhang, X., A. Haviland, A. Mehrotra, P. Huckfeldt, Z. Wagner and N. Sood. (2018). Does enrollment in high‐deductible health plans encourage price shopping? Health Services Research 53: 2718-34.

Stone, A. (2018). Ecological Momentary Assessment and Experience Sampling. In The Palgrave Handbook of Survey Research (pp. 563-571). Palgrave Macmillan, Cham.

Stone, A. A. (2018). Ecological Momentary Assessment in Survey Research. In The Palgrave Handbook of Survey Research (pp. 221-226). Palgrave Macmillan, Cham.

Junghaenel, D. U., Broderick, J. E., Schneider, S., May, M., Bolton, A., McCarrier, K. P., … & Stone, A. A. (2018). Frames of Reference in Self-Reports of Health, Well-Being, Fatigue, and Pain: a Qualitative ExaminationApplied Research in Quality of Life, 13(3), 585-601.

Stone, A.A. & A.B. Krueger.(2018) Understanding Subjective Well-Being. For Good Measure Advancing Research on Well-being Metrics Beyond GDP (OECD Publishing).

May, M., Junghaenel, D. U., Ono, M., Stone, A. A., & Schneider, S. (2018). Ecological Momentary Assessment Methodology in Chronic Pain Research: A Systematic Review. The Journal of Pain, 19(7), 699-716.

Newman, D. B., Schwarz, N., Graham, J., & Stone, A. A. (2018). Conservatives Report Greater Meaning in Life Than Liberals. Social Psychological and Personality Science, 10(4), 494-503.

Stone, A. A., Schneider, S., Junghaenel, D. U., Broderick, J. E. (2018). Response styles confound the age gradient of four health and well-being outcomes. Social Science Research, 78, 215-225

Schneider, S., Junghaenel, D. U., Ono, M., & Stone, A. A. (2018). Temporal dynamics of pain: an application of regime-switching models to ecological momentary assessments in patients with rheumatic diseases. Pain, 159(7), 1346-1358.

Stone, A. A., Schneider, S., Krueger, A., Schwartz, J. E., & Deaton, A. (2018). Experiential wellbeing data from the American Time Use Survey: Comparisons with other methods and analytic illustrations with age and income. Social Indicators Research, 136(1), 359-378.

Schneider, S., May, M., & Stone, A. A. (2018). Careless responding in internet-based quality of life assessmentsQuality of Life Research, 1-12.

Walentynowicz, M., Schneider, S., & Stone, A. A. (2018). The effects of time frames on self-report. PloS one, 13(8), e0201655.

Howard, D. H., Herring, B., Graves, J., Trish, E. (2018). Provider-Owned Insurers in the Individual Market. The American Journal of Managed Care, 24 (12), e393-398.

Lieberman, S., Trish, E., Adler, L., Antos, J., Bertko, J., and P. Ginsburg. (2018). A Proposal to Enhance Competition and Reform Bidding in the Medicare Advantage Program. USC- Brookings Schaeffer Initiative White Paper.

Ning, N., E. Trish, S. Axeen, D. P. Goldman and J. A. Romley. (2018). Do commercial health care prices influence Medicare spending? Value in Health 21 (suppl. 1): S263.

Trish, E., J. Xu and G. Joyce. (2018). Growing number of unsubsidized Part D beneficiaries with catastrophic spending suggests need for an out-of-pocket cap. Health Affairs 37 (7): 1048-56.

Zhang, X., E. Trish and N. Sood. (2018). Financial burden of healthcare utilization in consumer-directed health plans. American Journal of Managed Care 24 (4): e115-21.

Cheng, W., J. P. Hlavka, E. Snowberg, K. Van Nuys and D. P. Goldman. (2018). Three-part pricing to reward pharmaceutical innovation and increase access: Case of PCSK9 inhibitors. Value in Health, 21 (suppl. 1): S65.

Van Nuys, K., G. Joyce, R. Ribero and D. P. Goldman. (2018). Frequency and magnitude of co-payments exceeding prescription drug costs. JAMA, 319 (10): 1045-47.

Van Nuys, K., G. Joyce, R. Ribero and D. P. Goldman. (2018). Overpaying for prescription drugs: The copay clawback phenomenon. USC Leonard D. Schaeffer Center for Health Policy & Economics White Paper.

Van Nuys, K., Joyce, G., Ribero, R., & Goldman, D. P. (2018). Prescription Drug Copayment Coupon Landscape. Schaeffer Center White Paper.

Van Nuys, K. and Goldman, D. (2018). Reining in Pharmaceutical Costs. Schaeffer Center White Paper.

Van Nuys, K. E., Z. Xie, B. Tysinger, M. A. Hlatky and D. P. Goldman. (2018). Innovation in heart failure treatment: Life expectancy, disability and health disparities. JACC: Heart Failure, 6(5), 401-409.

Arevian, A. C., Bell, D., Kretzman, M., Kasari, C., Narayanan, S., Kesselman, C., Wu, S., Di Capua, P., Hsu, W., Keener, M., Pevnick, J., Wells, K. B., Chung, B. (2018). Participatory Methods to Support Team Science Development for Predictive Analytics in Health. Journal of Clinical and Translational Science, 2 (3), 178-182.

Guerrero, E., Alibrahim, A., Acevedo, A., Jin, H., Wu, S. (2018). System Stability: The role of Treatment Program Size and Performance on Closure. Academy of Management Proceedings, 2018 (1).

Li, M., Hagedon, A., Pan, L., Hsiao, H., Chi, I., Wu, S. (2018). Obstacles of Utilizing Self-Management App for Taiwanese Type II Diabetes Patients. Human Aspects of IT for the Aged Population. Applications in Health, Assistance, and Entertainment. ITAP 2018. Lecture Notes in Computer Science, 10927.

Wu, S., Hay, J., et. Al. (2018). Comparative Effectiveness of a Technology-Facilitated Depression Care Management Model in Safety-Net primary Care Patients with Type 2 Diabetes: 6 Month Outcomes of a Large Clinical Trial. Journal of Medical Internet Research, 20 (4), e147.

Chen, C., & Zissimopoulos, J. M. (2018). Racial/Ethnic disparities in the Health of Spousal Caregivers for Persons with and without Dementia Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14(7), P576-P577.

Chen, C., & J. M. Zissimopoulos. (2018). Racial and ethnic differences in trends in dementia prevalence and risk factors in the United StatesAlzheimer’s & Dementia: Translational Research & Clinical Interventions.

Lee, H., D. Myers, G. Painter, J. Thunell and J. Zissimopoulos. (2018). The role of parental financial assistance in the transition to homeownership by young adults. Journal of Housing Economics.

Zissimopoulos, J. M., B. C. Tysinger, P. A. St. Clair and E. C. Crimmins. (2018). The impact of changes in population health and mortality on future prevalence of Alzheimer’s disease and other dementias in the United States. Journals of Gerontology: Series B 73 (1): S38-47.